Figure S1.
SG formation during lysosomal damage. (A) Immunoblot analysis of proteins associated with purified lysosomes (LysoIP; anti-HA immunoprecipitation TMEM1923xHA) from HEK293T cells treated with 2 mM LLOMe or 100 µM NaAsO2 for 30 min. TMEM1922xFLAG, control. (B) Quantification by HCM of DCP1a and G3BP1 puncta in U2OS cells treated with 2 mM LLOMe for 30 min. PB, P-body. (C) Quantification by HCM of G3BP1 puncta in Huh7 cells treated with 2 mM LLOMe for 30 min. White masks, algorithm-defined cell boundaries (primary objects); Green masks, computer-identified G3BP1 puncta (target objects). (D) Quantification by HCM of Gal3 puncta in BMM cells treated with 2 mM LLOMe or 100 µM NaAsO2 for 2 h. Red masks, computer-identified galectin-3 puncta. (E) Quantification by HCM of TIA1 puncta in U2OS cells treated with 2 mM LLOMe for 30 min. Red masks, computer-identified TIA1 puncta. (F) Quantification by HCM of TIA1 puncta in HeLa cells treated with 4 mM LLOMe for 30 min. Red masks, computer-identified TIA1 puncta. (G) Quantification by HCM of G3BP1 and Gal3 puncta in U2OS cells treated with increasing doses of LLOMe or 100 µM NaAsO2 in the presence or absence of 10 µg/ml cycloheximide (CHX) for 30 min. (i) HCM sample images corresponding to Fig. 1 F. Red masks, computer-identified G3BP1 puncta. (ii and ⅲ) Green masks, computer-identified Gal3 puncta and corresponding quantification in iii. (H) Immunoblot analysis of eIF2α (S51) phosphorylation in U2OS cells treated with 2 mM LLOMe for 30 min and followed by 1 h washout. (I) Quantification by HCM of G3BP1 puncta in U2OS cells treated with 2 mM LLOMe for 30 min and followed by 1 h washout. Red masks, computer-identified G3BP1 puncta. (J) Immunoblot analysis of eIF2α (S51) phosphorylation in HEK293T cells treated with 2 mM LLOMe or 100 µM NaAsO2 for 30 min. (K) Schematic summary of the findings in Fig. 1. (L) Quantification by HCM of Lysotracker Red (LTR) and G3BP1 puncta in parental HeLa WT and Gal3KO cells treated with 4 mM LLOMe for 30 min. Red masks, computer-identified LTR puncta. Green masks, computer-identified G3BP1 puncta. (M) Quantification by HCM of poly(A) RNA (Cy3-oligo[dT]) in U2OS cells transfected with scrambled siRNA as control (SCR) or G3BP1/2 siRNA for single or double knockdown (DKD). Cells were treated with 2 mM LLOMe for 30 min. Red masks, computer-identified poly(A) RNA puncta. Ctrl, control (untreated cells). Data, means ± SEM; HCM: n ≥ 3 (each experiment: 500 valid primary objects/cells per well, ≥5 wells/sample). †, P ≥ 0.05 (not significant); **, P < 0.01, ANOVA. See also Fig. 1. Source data are available for this figure: SourceData FS1.